City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
Click here to login to Secure Web Site  (authorized users only)  
  
Search results:  230  Clinical trial(s) found  (Page 1 of 46 )
  [Next>]
Click here to generate a printer-friendly view  
The following studies are available for :
 10061
   P.I.: Joanne Mortimer, MD (Industrial)
Title: Biomarker Evaluation and Selection of Targeted Therapy (BEST-Rx)
 10055
   P.I.: Paul Lin, MD (Cooperative Group)
Title: GOG 0240: A Randomized Phase III Trial of Cisplatin Plus Paclitaxel with and without NCI-Supplied Bevacizumab (NSC #704865, IND #7921) Versus the Nonplatinum Doublet, Topotecan Plus Paclitaxel, with and without NCI-Supplied Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix
 
Click here for  Full Eligibility Criteria
 10051
   P.I.: Nayana Vora, MD (Cooperative Group)
Title: RTOG 0724: Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High-Risk Patients with Early-Stage Cervical Carcinoma Following Radical Hysterectomy
 
Click here for  Full Eligibility Criteria
 10040
   P.I.: Warren Chow, MD (Industrial)
Title: The TEAM trial (Tasigna efficacy in advanced melanoma): A randomized, phase III, open label, multi-center, two-arm study to compare the efficacy of Tasigna versus decarbazine (DTIC) in the treatment of patients with metastatic and/or inoperable melanoma harboring a c-Kit mutation
 
Click here for  Full Eligibility Criteria
 10035
   P.I.: Vijay Trisal, MD (Industrial)
Title: An Exploratory Analysis of Tumor Specific T Cells in Subjects with Clinically and Histologically Diagnosed Cancer
  [Next>]

  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and urology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.